ArticleCancer immunology, immunotherapy : CII2023

Egr2 and 3 maintain anti-tumour responses of exhausted tumour infiltrating CD8 + T cells.

Alistair L J Symonds et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.